DHSA:LSE:LSE-WisdomTree US Equity Income UCITS ETF - Acc (USD)

ETF | Others |

Last Closing

USD 29.305

Change

-0.01 (-0.02)%

Market Cap

N/A

Volume

116.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+13.40 (+7.84%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.04%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.01 (+0.04%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+1.60 (+1.54%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.10 (-1.48%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 259.48B
0QZO:LSE 0QZO

+3.90 (+4.55%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+1.30 (+0.91%)

USD 202.26B
0R24:LSE Intel Corp.

+1.51 (+7.71%)

USD 196.14B

ETFs Containing DHSA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.36% 42% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.36% 42% F 47% F
Trailing 12 Months  
Capital Gain 9.43% 79% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.43% 75% C 71% C-
Trailing 5 Years  
Capital Gain 77.34% 71% C- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.34% 69% C- 74% C
Average Annual (5 Year Horizon)  
Capital Gain 12.31% 73% C 74% C
Dividend Return 12.31% 73% C 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.51% 54% F 72% C
Risk Adjusted Return 98.34% 88% B+ 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike